Latest News

Date Title Topic
17 Oct 2017 EMA Recommends Extension of Indications for Abiraterone Acetate Genitourinary cancers - Anticancer agents & Biologic therapy
16 Oct 2017 EMA Recommends Extension of Indications for Alectinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
13 Oct 2017 Paediatric, Adolescent, and Young Adult Survivors of Hodgkin’s Disease Face an Elevated Risk of Cardiovascular Disease Haematologic malignancies - Cancer in Special Situations
11 Oct 2017 Countdown to Launch of New EudraVigilance System Bioethics, legal and economic issues
09 Oct 2017 Exploring Opportunities for Collaboration Between Regulators and Healthcare Payers Bioethics, legal and economic issues
06 Oct 2017 NICE Issues Technology Appraisal Guidance for Brentuximab Vedotin Haematologic malignancies - Anticancer agents & Biologic therapy
05 Oct 2017 Therapeutic Targeting of p53 Translational research
04 Oct 2017 FDA Grants Accelerated Approval to Nivolumab for HCC Previously Treated With Sorafenib Gastrointestinal cancers - Cancer Immunology and Immunotherapy
03 Oct 2017 FDA Grants Accelerated Approval to Copanlisib for Relapsed Follicular Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
02 Oct 2017 FDA Approves Abemaciclib for HR-positive, HER2-negative Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
29 Sep 2017 EMA Recommends Granting a Marketing Authorisation for Padeliporfin Genitourinary cancers
28 Sep 2017 NICE Develops a Medtech Innovation Briefing on Caris Molecular Intelligence for Guiding Cancer Treatment Personalised medicine
eUpdate – Treatment Recommendation
27 Sep 2017 FDA Approves Lower Dose of Cabazitaxel for mCRPC Genitourinary cancers - Anticancer agents & Biologic therapy
25 Sep 2017 FDA Grants Accelerated Approval to Pembrolizumab for Advanced Gastric Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy